Cite

HARVARD Citation

    Kim, H. et al. (2022). Lenvatinib in multimodal therapy for unresectable radioactive iodine‐naïve differentiated thyroid cancer: A case report with literature review. Cancer reports. 5 (10), p. n/a. [Online]. 
  
Back to record